{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:15:36Z","timestamp":1793884536520,"version":"4.7.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Open Science"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.euros.2025.09.003","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T20:16:32Z","timestamp":1758831392000},"page":"44-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Defining the Minimal Important Difference in International Prostate Symptom Score for Men with Lower Urinary Tract Symptoms Using a Patient-centered Anchor Measure"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7071-8312","authenticated-orcid":false,"given":"Laura","family":"Wiemer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Lehmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Sch\u00f6nburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gratzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Patrick Papp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euros.2025.09.003_b0005","series-title":"EAU guidelines on management of non-neurogenic male lower urinary tract symptoms (LUTS) incl. benign prostatic obstruction (BPO)","author":"Gravas","year":"2022"},{"key":"10.1016\/j.euros.2025.09.003_b0010","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.eururo.2016.07.007","article-title":"Male lower urinary tract symptoms and cardiovascular events: a systematic review and meta-analysis","volume":"70","author":"Gacci","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2025.09.003_b0015","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1097\/JU.0000000000002450","article-title":"Lower urinary tract symptoms and mortality among Finnish men: the roles of symptom severity and bother","volume":"207","author":"Akerla","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2025.09.003_b0020","series-title":"EAU guidelines on the management of non-neurogenic male lower urinary tract symptoms (LUTS)","author":"Cornu","year":"2024"},{"key":"10.1016\/j.euros.2025.09.003_b0025","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0022-5347(17)36966-5","article-title":"The American Urological Association Symptom Index for benign prostatic hyperplasia","volume":"148","author":"Barry","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2025.09.003_b0030","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/luts.12415","article-title":"How international is the International Prostate Symptom Score? A literature review of validated translations of the IPSS, the most widely used self-administered patient questionnaire for male lower urinary tract symptoms","volume":"14","author":"Yao","year":"2022","journal-title":"Lower Urin Tract Symptoms"},{"key":"10.1016\/j.euros.2025.09.003_b0035","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/S0022-5347(01)66780-6","article-title":"Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association Symptom Index and the Benign Prostatic Hyperplasia Impact Index is perceptible to patients?","volume":"154","author":"Barry","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2025.09.003_b0040","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-032795","article-title":"Determining the minimal important differences in the International Prostate Symptom Score and Overactive Bladder Questionnaire: results from an observational cohort study in Dutch primary care","volume":"9","author":"Blanker","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.euros.2025.09.003_b0045","first-page":"262","article-title":"Predictors of achieving a minimal clinically important difference in lower urinary tract symptoms 3 months after Rezum therapy","volume":"77","author":"Babar","year":"2024","journal-title":"Cent Eur J Urol"},{"key":"10.1016\/j.euros.2025.09.003_b0050","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.eururo.2010.10.046","article-title":"Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe","volume":"59","author":"Chapple","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2025.09.003_b0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1370\/afm.2609","article-title":"Self-management for men with lower urinary tract symptoms: a systematic review and meta-analysis","volume":"19","author":"Albarqouni","year":"2021","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.euros.2025.09.003_b0060","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2400290","article-title":"A randomized trial of an app-based therapeutic for lower urinary tract symptoms","volume":"4","author":"Gratzke","year":"2025","journal-title":"NEJM Evid"},{"key":"10.1016\/j.euros.2025.09.003_b0065","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2490-12-30","article-title":"Construct validation of Patient Global Impression of Severity (PGI-S) and Improvement (PGI-I) questionnaires in the treatment of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"12","author":"Viktrup","year":"2012","journal-title":"BMC Urol"},{"key":"10.1016\/j.euros.2025.09.003_b0070","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jclinepi.2020.11.024","article-title":"Minimal important difference estimates for patient-reported outcomes: a systematic survey","volume":"133","author":"Carrasco-Labra","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.euros.2025.09.003_b0075","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1023\/A:1015276414526","article-title":"Meaningful change in cancer-specific quality of life scores: differences between improvement and worsening","volume":"11","author":"Cella","year":"2002","journal-title":"Qual Life Res"},{"key":"10.1016\/j.euros.2025.09.003_b0080","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0895-4356(02)00435-3","article-title":"A critical look at transition ratings","volume":"55","author":"Guyatt","year":"2002","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.euros.2025.09.003_b0085","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDe2500055","article-title":"Beyond medications - the promise of app-based digital therapeutics for lower urinary tract symptoms","volume":"4","author":"Elterman","year":"2025","journal-title":"NEJM Evid"},{"key":"10.1016\/j.euros.2025.09.003_b0090","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.jval.2022.07.010","article-title":"Is IQWiG\u2019s 15% threshold universally applicable in assessing the clinical relevance of patient-reported outcomes changes? An ISPOR Special Interest Group Report","volume":"25","author":"Schlichting","year":"2022","journal-title":"Value Health"},{"key":"10.1016\/j.euros.2025.09.003_b0095","unstructured":"Institut f\u00fcr Qualit\u00e4t und Wirtschaftlichkeit im Gesundheitswesen. IQWiG general methods version 6.0. Cologne, Germany: IQWiG; 2020. https:\/\/www.iqwig.de\/methoden\/general-methods_version-6-0.pdf."},{"key":"10.1016\/j.euros.2025.09.003_b0100","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jclinepi.2017.06.009","article-title":"Minimal important difference to infer changes in health-related quality of life\u2014a systematic review","volume":"89","author":"Jayadevappa","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.euros.2025.09.003_b0105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12178-020-09684-2","article-title":"Minimal clinically important difference, substantial clinical benefit, and patient acceptable symptom state of outcome measures relating to shoulder pathology and surgery: a systematic review","volume":"14","author":"Su","year":"2021","journal-title":"Curr Rev Musculoskelet Med"}],"container-title":["European Urology Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168325003040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168325003040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T17:46:18Z","timestamp":1773164778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666168325003040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":21,"alternative-id":["S2666168325003040"],"URL":"https:\/\/doi.org\/10.1016\/j.euros.2025.09.003","relation":{},"ISSN":["2666-1683"],"issn-type":[{"value":"2666-1683","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining the Minimal Important Difference in International Prostate Symptom Score for Men with Lower Urinary Tract Symptoms Using a Patient-centered Anchor Measure","name":"articletitle","label":"Article Title"},{"value":"European Urology Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euros.2025.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}